Tim Leiner, MD PhD

[Tim Leiner @MRAguy]

Reactie van Nederlandse Vereninging voor Radiologie op uitspraak EMA inzake gadolinium-houdende contrastmiddelen https://t.co/2dhSCt3rR4

[Tim Leiner @MRAguy]

Final European Medicines Agency PRAC decision out on gadolinium-containing contrast agents https://t.co/hghslA1g6u

[Tim Leiner, MD PhD @ContrastSafety]

PRAC confirms restrictions on the use of linear gadolinium agents https://t.co/WF2pJ7V8Lu

[Tim Leiner @MRAguy]

FDA finds no health effects of from gadolinium retention https://t.co/KFy3b1A4xG #gadolinium #radiology

[Tim Leiner @MRAguy]

Reaction of Am Coll Radiology to EMA's recommendation to take linear gadolinium chelates off the market https://t.co/g6CxJVmVWi #gadolinium

[Tim Leiner, MD PhD @ContrastSafety]

Up to 20 doses gadobutrol do not change dentate nucleus R1 when measured with serial relaxometry (free full text): https://t.co/x8RDykjdDw

[Tim Leiner @MRAguy]

Breaking news: EMA suspends marketing authorization for all linear gadolinium chelates #gadolinium #gbca #mri https://t.co/K7FLEByKZK

[Tim Leiner @MRAguy]

New evidence in @TheLancet that prophylactic hydration to prevent CIN is not necessary https://t.co/glFPXiN89i

[Aart Van Der Molen @CTenthousiast]

@RSNA @contrastsafety #RSNA16: Meet the Masters from the Netherlands at RSNA Booth 8519

[Tim Leiner, MD PhD @ContrastSafety]

Jaar lang roken geeft 150 mutaties in iedere longcel https://t.co/KSliP16qZh via @NTvG_actueel

[Tim Leiner @MRAguy]

Gadolinium chelates for MRI: Where are we now? https://t.co/jGsl7MQYeF

[Tim Leiner, MD PhD @ContrastSafety]

Safety data of 35,499 patients given gadoterate dimeglumine GBCA confirms excellent safety profile https://t.co/veDmgzX6FR #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

Now also a case of T1-shortening of the cerebral cortex after gadolinium administration https://t.co/iVR6154umX #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

Interesting exploration of alternatives to gadolinium for use as MR contrast agents https://t.co/IqMH2urk5h #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

MRI Contrast Agents: Evolution of Clinical Practice and Dose Optimization https://t.co/WN1NYXwVVO #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

Review of changes in practice patterns due to adverse effects of gadolinium-based contrast agents https://t.co/DHRltC0DKh #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

New review on the role of contrast agents in MR Imaging https://t.co/NMyUKnKYC5 #contrastsafety

[Tim Leiner @MRAguy]

Interested in contrast agents? You might like this: https://t.co/NZmycperwa #contrastagents

[Tim Leiner, MD PhD @ContrastSafety]

Interesting! Negative oral contrast in abdominal CT imaging leads to higher radiation dose https://t.co/V48r1Ddzvc #contrastsafety

[Tim Leiner, MD PhD @ContrastSafety]

Review on gadolinium tissue deposition in brain and bone https://t.co/Gq5CHZOkTh #contrastsafety